Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EXACT SCIENCES CORPORATION

(EXAS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société EXACT SCIENCES CORPORATION
01/19EXACT SCIENCES : Presents Data Showing Improved Accuracy of Second-generation Cologuard® T..
PU
01/10EXACT SCIENCES : Announces Preliminary Fourth Quarter 2021 Results - Form 8-K
PU
01/09Exact Sciences Acquires PreventionGenetics to Accelerate Availability of Hereditary Can..
PR
01/09Exact Sciences and OncXerna Announce Licensing Agreement to Help Predict Immunotherapy ..
PR
01/03EXACT SCIENCES : Madison School Nurses Tour COVID-19 Lab
PU
01/03EXACT SCIENCES : Supporting Afghan Refugee Efforts
PU
01/03Exact Sciences to participate in J.P. Morgan Healthcare Conference
PR
2021EXACT SCIENCES : Receives 2021 Climate Champion Awards
PU
2021EXACT SCIENCES : Commits $500,000 to Urban League Black Business Hub
PU
2021New Data Presented at SABCS® 2021 Strengthen Value of Oncotype DX Breast Recurrence Sco..
PR
2021EXACT SCIENCES : Going the Extra Mile
PU
2021Publication in The New England Journal of Medicine Confirms that Tens of Thousands of W..
PR
2021EXACT SCIENCES : Presentation
PU
2021New 20-Year Data Published in Urologic Oncology Validates Adverse Pathology as Predicto..
PR
2021Exact Sciences and Jefferson Health Commence Collaboration on Multi-Cancer Earlier Dete..
PR
2021EXACT SCIENCES : Q3 Earnings Snapshot
AQ
2021EXACT SCIENCES CORP Management's Discussion and Analysis of Financial Condition and Re..
AQ
2021Exact Sciences announces third quarter 2021 results - Form 8-K
PU
2021Exact Sciences to participate in November investor conferences
PR
2021New Cologuard® Modeling Data Show Patient Navigation Matters When Reaching Underserved ..
PU
2021EXACT SCIENCES : Hosts Maydm Interns
PU
2021EXACT SCIENCES : schedules third quarter 2021 earnings call
PR
2021EXACT SCIENCES : to Present New Oncotype DX Genomic Prostate Score® Test Data and Exhibit ..
PU
2021EXACT SCIENCES : to participate in September investor conferences
PR
2021RENALYTIX : Appoints Daniel J. Levangie to its Board of Directors
AQ
2021EXACT SCIENCES : receives regulatory approval for the Oncotype DX Breast Recurrence Score®..
PR
2021EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2021EXACT SCIENCES : Announces Second Quarter 2021 Results (Form 8-K)
PU
2021EXACT SCIENCES : Q2 Earnings Snapshot
AQ
2021EXACT SCIENCES : schedules second quarter 2021 earnings call
PR
2021EXACT SCIENCES : New Analysis Reinforces Cost-Effectiveness of the Oncotype DX Breast Recu..
PU
2021EXACT SCIENCES : Strengthens Evidence Supporting Cologuard® and Oncotype DX® Tests and Dee..
PU
2021EXACT SCIENCES : to participate in June investor conferences
PR
2021EXACT SCIENCES : New Analysis Reinforces Cost-Effectiveness of the Oncotype DX Breast Recu..
PU
2021EXACT SCIENCES : Applauds Final Task Force Recommendation That Lowers Starting Age for Col..
PU
2021EXACT SCIENCES : New Analysis Reinforces Cost-Effectiveness of the Oncotype DX Breast Recu..
PU
2021EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2021EXACT SCIENCES : Q1 Earnings Snapshot
AQ
2021EXACT SCIENCES : Announces First Quarter 2021 Results
PU
2021EXACT SCIENCES : Departure of Directors or Principal Officers; Election of Directors; Appo..
PU
2021EXACT SCIENCES : to participate in May investor conferences
PR
2021EXACT SCIENCES : Completes Acquisition of Ashion Analytics, LLC, from The Translational Ge..
PR
2021EXACT SCIENCES : schedules first quarter 2021 earnings call
PR
2021EXACT SCIENCES : New NCCN Breast Cancer Guidelines Recognize Oncotype DX Breast Recurrence..
PU
2021EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2021EXACT SCIENCES : 4Q Earnings Snapshot
AQ
2021THE TRUTH ABOUT CANCER : Debunking Five Myths about the Big C
PU
2021EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2021Jefferies, Exxon rise; Exact Sciences, WW International fall
AQ
2021EXACT SCIENCES CORP : Results of Operations and Financial Condition, Change in Directors o..
AQ
2020EXACT SCIENCES : RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spa..
PU
2020EXACT SCIENCES : $10 million grant from exact sciences to support stand up to cancer initi..
PU
2020EXACT SCIENCES : RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spa..
AQ
2020EXACT SCIENCES : Vice President Defends Education System Based On Exact Sciences
AQ
2020EXACT SCIENCES CORP : Other Events (form 8-K)
AQ
2020EXACT SCIENCES : Policy Governing Director Nominations
PU
2020EXACT SCIENCES : Code of Business Conduct and Ethics
PU
2020EXACT SCIENCES : Infographic
PU
2020EXACT SCIENCES : 3Q Earnings Snapshot
AQ
2020EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2020EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2020EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2020EXACT SCIENCES : 2Q Earnings Snapshot
AQ
2020EXACT SCIENCES : 1Q Earnings Snapshot
AQ
2020EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2020EXACT SCIENCES CORP : Change in Directors or Principal Officers (form 8-K)
AQ
2020EXACT SCIENCES : Message from Chairman & CEO, Kevin Conroy
PU
2020EXACT SCIENCES : Fight colorectal cancer reciveces grant from exact sciences to launch pro..
PU
2020EXACT SCIENCES : SEC Filing (424B7)
PU
2020EXACT SCIENCES : Management's Discussion and Analysis of Financial Condition and Results o..
AQ
2020EXACT SCIENCES : SEC Filing - CT ORDER
PU
2020EXACT SCIENCES : 4Q Earnings Snapshot
AQ
2020EXACT SCIENCES CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fin..
AQ
2019EXACT SCIENCES CORP : Other Events (form 8-K)
AQ
2019EXACT SCIENCES : to host annual meeting, second-quarter 2019 results webcasts and calls
PU
1  2  3  4  5  6Next